P M Sweetnam

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +9

EFFECTS OF CHANGES IN FAT, FISH, AND FIBRE INTAKES ON DEATH AND MYOCARDIAL REINFARCTION: DIET AND REINFARCTION TRIAL (DART)

M L Burr, James Gilbert, Ruth M. Holliday et al. · The Lancet · 1989 · 2.6K citations

Obesity, Nutrition, Cardiovascular Disease +9

Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies.

J. W. G. Yarnell, Ian Baker, P M Sweetnam et al. · Circulation · 1991 · 924 citations · Full text

A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial Infarction

P C Elwood, Alexandra Cochrane, M L Burr et al. · BMJ · 1974 · 518 citations · Full text

Hypertension, Heart Failure, Total Mortality +17

Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study

M.G.L. Hertog, P M Sweetnam, A M Fehily et al. · American Journal of Clinical Nutrition · 1997 · 514 citations

Metabolic Syndrome, Cardiovascular Disease, Medicine +10